GAIL SADLER: Open Payments
NPI 1083691075 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,560 in 78 payments from 24 companies in 2025. Trend: 2023 $1,510 · 2024 $2,315 · 2025 $3,560
Food & beverage: $3,560
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $640 |
| AstraZeneca Pharmaceuticals LP | 5 | $394 |
| Novo Nordisk Inc | 13 | $341 |
| Corcept Therapeutics | 8 | $221 |
| ABBVIE INC. | 4 | $217 |
| Xeris Pharmaceuticals, Inc. | 4 | $177 |
| Abbott Laboratories | 1 | $157 |
| Dexcom, Inc. | 2 | $148 |
| Actelion Pharmaceuticals US, Inc. | 1 | $148 |
| Boston Scientific Corporation | 1 | $129 |
Products named: BREZTRI, OTEZLA, Ozempic, Korlym, RECORLEV, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, UPTRAVI, REPATHA.
Industry payments across FL — which companies pay providers there.
